A study published in Diabetes Care has revealed that children with acute recurrent or chronic pancreatitis who test positive ...

For categorical analyses, the reference group was women without type 2 diabetes and a fasting C-peptide level less than 1.7 ng/mL. Size of tertile categories may not be equal because of some women ...

A major new meta-analysis from the Institute of Psychiatry, Psychology & Neuroscience (IoPPN) at King's College London has ...

Diabetes is a leading global health and economic challenge, affecting over 800 million people worldwide, with over 80% ...

Fat cells are also metabolically active and can cause a chronic state of inflammation in the part of the body where they ...

MBX Biosciences is advancing a unique prodrug pipeline with key GLP-1 assets and a pivotal Phase 2 readout in ...

Genprex, Inc. is a clinical-stage gene therapy company focused on developing life-changing therapies for patients with cancer and diabetes ... increases in c-peptide levels and improvements ...

Preclinical data from an animal study of GPX-002 in T1D showed statistically significant decreases in insulin requirements, increases in c-peptide levels and improvements ... our pioneering gene ...

Novel Gene Therapy is Addressing Both Type 1 and Type 2 Diabetes AUSTIN, Texas, May 28, 2025 /PRNewswire/ -- Genprex, Inc. (Genprex or th ...

MODY 5 is a rare genetic diabetes subtype caused by HNF1B mutations or deletions, often presenting with early-onset diabetes and kidney, liver, or pancreatic abnormalities. Accurate genetic diagnosis ...

Preclinical data from an animal study of GPX-002 in T1D showed statistically significant decreases in insulin requirements, increases in c-peptide levels ... therapy work in diabetes through ...

Learn how emerging technologies are enhancing patient engagement and treatment strategies in everyday practice.